MAPK3 and rheumatoid arthritis: We observed that, in contrast to TNF-α-induced Cyp7b activity, the MEK1/ERK1/2 inhibitor PD98059 and p38 inhibitor SB203580 reduced the TNF-α-induced IL-6 production in several RA FLS tested (data not shown).